September 30, 2026 at 08:18 PM UTC
BIOMARIN PHARMACEUTICAL INC reports material agreement in SEC 8-K
BIOMARIN PHARMACEUTICAL INC filed an 8-K covering a material definitive agreement. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 30, 2026 at 08:15 PM UTC
Open official source